(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.08%) $79.06
(5.02%) $2.03
(0.10%) $2 313.40
(0.68%) $26.93
(0.85%) $963.00
(-0.07%) $0.932
(-0.27%) $11.00
(-0.07%) $0.798
(-2.30%) $91.12
Live Chart Being Loaded With Signals
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States...
Stats | |
---|---|
Šios dienos apimtis | 8.32M |
Vidutinė apimtis | 267 677 |
Rinkos kapitalizacija | 1.78M |
EPS | $0 ( 2024-03-25 ) |
Kita pelno data | ( $0 ) 2024-05-14 |
Last Dividend | $50.40 ( 2016-01-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.416 |
ATR14 | $0.0430 (17.84%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-26 | Dyer Jeffrey Hansen | Buy | 42 986 | Common Stock |
2023-01-26 | Dyer Jeffrey Hansen | Sell | 200 | Stock option (right to buy) |
2023-01-26 | Dyer Jeffrey Hansen | Sell | 0 | Common Stock |
2023-01-12 | Nolet Chris | Sell | 36 497 | Common Stock |
2023-01-12 | Nolet Chris | Sell | 3 078 | Stock option (right to buy) |
INSIDER POWER |
---|
54.11 |
Last 99 transactions |
Buy: 3 157 109 | Sell: 846 689 |
Tūris Koreliacija
PolarityTE Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
PolarityTE Inc Koreliacija - Valiuta/Žaliavos
PolarityTE Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $814 000 |
Bruto pelnas: | $198 000 (24.32 %) |
EPS: | $1.490 |
FY | 2022 |
Pajamos: | $814 000 |
Bruto pelnas: | $198 000 (24.32 %) |
EPS: | $1.490 |
FY | 2021 |
Pajamos: | $9.40M |
Bruto pelnas: | $5.09M (54.10 %) |
EPS: | $-9.50 |
FY | 2020 |
Pajamos: | $10.13M |
Bruto pelnas: | $5.70M (56.31 %) |
EPS: | $-27.75 |
Financial Reports:
No articles found.
PolarityTE Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $50.33 | 2016-01-12 |
Last Dividend | $50.40 | 2016-01-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $100.73 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.02 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $100.73 | 65.20% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | 0.676 | 1.200 | 10.00 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.841 | 1.500 | 1.769 | 2.65 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 4.11 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.15 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.94 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.164 | -1.500 | 7.27 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -685.22 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.281 | 2.00 | -0.427 | -0.854 | [0 - 30] |
freeCashFlowPerShareTTM | -1.285 | 2.00 | -0.643 | -1.285 | [0 - 20] |
debtEquityRatioTTM | 0.238 | -1.500 | 9.05 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -3.18 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 0.145 | 1.000 | -0.0864 | 0 | [1 - 100] |
returnOnEquityTTM | 0.841 | 2.50 | 4.71 | 2.65 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.285 | 2.00 | -0.428 | -1.285 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.281 | 2.00 | -0.427 | -0.854 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0105 | 1.500 | -3.26 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | 0.0808 |
PolarityTE Inc
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.